UPDATE: ISI Group Initiates Qiagen with Underweight, $15 PT on Muted BioPharma and Academic Segments - Qiagen (NYSE:QGEN)

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.

ISI Group initiated its coverage on Qiagen (NASDAQ: QGEN) with a rating of Underweight and a $15 price target. ISI Group commented, "We are initiating coverage on shares of Qiagen with an Underweight rating and a price target of $15.00, which on a forward basis equates to ~10x EV/EBITDA and ~14x operating EPS. Our thesis for QGEN is based on potential global research budget challenges translating into a muted outlook for the academic and biopharma segments, slowing growth in the HPV franchise, and the need for sustained R&D investments (companion diagnostic agreements) capping medium-term earnings growth."Qiagen closed at $17.03 on Monday.

27% profit every 20 days?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!